Q. No.Match List I with List II:
Choose the correct answer from the options given below:
1. A-III, B-I, C-II, D-IV
2. A-III, B-IV, C-I, D-II
3. A-II, B-IV, C-I, D-III
4. A-II, B-I, C-IV, D-III
| List I | List II | ||
| A. | \(\alpha-1\) antitrypsin | I. | Cotton bollworm |
| B. | Cry IAb | II. | ADA deficiency |
| C. | Cry IAc | III. | Emphysema |
| D. | Enzyme replacement therapy | IV. | Corn borer |
Choose the correct answer from the options given below:
1. A-III, B-I, C-II, D-IV
2. A-III, B-IV, C-I, D-II
3. A-II, B-IV, C-I, D-III
4. A-II, B-I, C-IV, D-III
Subtopic: Intro to Agri Applications | Bt Crops | Gene Therapy |
81%
From NCERT
NEET - 2024
Please attempt this question first.
Hints
Please attempt this question first.
Match List - I with List - II
Choose the correct answer from the options given below:
| List-I | List-II | ||
| (A) | Gene therapy | (I) | Separation of DNA fragments |
| (B) | RNA interference | (II) | Diagnostic test for AIDS |
| (C) | ELISA | (III) | Cellular defense |
| (D) | Gel Electrophoresis | (IV) | Allows correction of a gene defect |
Choose the correct answer from the options given below:
| Options: | (A) | (B) | (C) | (D) |
| 1. | IV | I | II | III |
| 2. | IV | II | III | I |
| 3. | IV | III | II | I |
| 4. | IV | III | I | II |
Subtopic: Interference RNA Tech | Med Applications & Humulin | Gene Therapy | Molecular Diagnosis |
90%
From NCERT
NEET - 2023
Please attempt this question first.
Hints
Please attempt this question first.
The genetic defect-Adenosine Deaminase (ADA) deficiency may be cured permanently by:
| 1. | periodic infusion of genetically engineered lymphocytes having functional ADA cDNA |
| 2. | administering adenosine deaminase activators |
| 3. | introducing bone marrow cells producing ADA into cells at early embryonic stages |
| 4. | invitro cell culture therapy |
Subtopic: Gene Therapy |
88%
From NCERT
AIPMT - 2009
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Hints
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
The site of production of ADA in the body is:
1. erythrocytes
2. lymphocytes
3. blood plasma
4. osteocytes
Subtopic: Gene Therapy |
87%
From NCERT
Please attempt this question first.
Hints
Please attempt this question first.
The first clinical gene therapy was done for the treatment of
| 1. | AIDS |
| 2. | Cancer |
| 3. | Cystic fibrosis |
| 4. | SCID (Severe Combined Immuno Deficiency resulting from the deficiency of ADA |
Subtopic: Gene Therapy |
94%
From NCERT
Please attempt this question first.
Hints
Please attempt this question first.
ADA is an enzyme which is deficient in a genetic disorder SCID. What is the full form of ADA?
1. Adenosine deoxyaminase
2. Adenosine deaminase
3. Aspartate deaminase
4. Arginine deaminase
Subtopic: Gene Therapy |
96%
From NCERT
Please attempt this question first.
Hints
Please attempt this question first.
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
| 1. | Genetically engineered lymphocytes are not immortal cells. |
| 2. | Retroviral vector is introduced into these lymphocytes. |
| 3. | Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages |
| 4. | Lymphocytes from patient's blood are grown in culture, outside the body. |
Subtopic: Gene Therapy |
74%
From NCERT
NEET - 2022
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Hints
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
When gene targeting involving gene amplification is attempted in an individual's tissue to treat disease, it is known as:
1. Molecular diagnosis
2. Safety testing
3. Biopiracy
4. Gene therapy
Subtopic: Gene Therapy |
69%
From NCERT
NEET - 2021
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Hints
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
The Adenosine deaminase deficiency results into:
| 1. | Digestive disorder | 2. | Addison's disease |
| 3. | Dysfunction of Immune system | 4. | Parkinson's disease |
Subtopic: Gene Therapy |
82%
From NCERT
NEET - 2021
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Hints
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Match the following columns and select the correct option.
| Column-I | Column-II | ||
| a. | Bt cotton | (i) | Gene therapy |
| b. | Adenosine deaminase deficiency | (ii) | Cellular defense |
| c. | RNAi | (iii) | Detection of HIV infection |
| d. | PCR | (iv) | Bacillus thuringiensis |
| a | b | c | d | |
| 1. | (iii) | (ii) | (i) | (iv) |
| 2. | (ii) | (iii) | (iv) | (i) |
| 3. | (i) | (ii) | (iii) | (iv) |
| 4. | (iv) | (i) | (ii) | (iii) |
Subtopic: Bt Crops | Interference RNA Tech | Gene Therapy | Molecular Diagnosis |
93%
From NCERT
NEET - 2020
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
Hints
To view explanation, please take trial in the course.
NEET 2025 - Target Batch
© 2024 GoodEd Technologies Pvt. Ltd.